Tranexamic Acid Within 4.5 Hours of Intracerebral Hemorrhage With the CTA Spot Sign, Systematic Review and Individual Patient Meta-Analysis
Neurol 103:e210104, Yassi,N.,et al, 2024
Out-of-Hospital Tranexamic Acid for Traumatic Brain Injury
JAMA 324:946-947, Cone, D.C.,et al, 2020
Effects of Tranexamic Acid on Death, Disability, Vascular Occlusive Events and Other Morbidities in Patients with Acute Traumatic Brain Injury (CRASH-3): A Randomised, Placebo-Controlled Trial
Lancet 394:1713-1723,1687, The CRASH-3 trial collaborators, 2019
Intracerebral Haemorrhage: Current Approaches to Acute Management
Lancet 392:1257-1268, Cordonnier, C.,et al, 2018
Tranexamic Acid-Associated Seizures: Causes and Treatment
Ann Neurol 79:18-26, Lecker, I.,et al, 2016
Subarachnoid Haemorrhage
BMJ 333:235-240, Al-Shahi,R.,et al, 2006
Antifibrinolytic Therapy for Aneurysmal Subarachnoid Hemorrhage, A Major Update of a Cochrane Review
Stroke 34:2308-2309, Roos,Y.,et al, 2003
Tranexamic Acid in Hereditary Hemorrhagic Telangiectasia
NEJM 346:457, Sabra,C.,et al, 2002
Antifibrinolytic Treatment in Subarachnoid Hemorrhage, A Randomized Placebo-Controlled Trial
Neurol 54:77-82, Roos,Y.,STAR Study Group, 2000
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
Stroke 25:2315-2328, Mayberg,M.R.,et al, 1994
Cerebral Sinus Thrombosis as a Potential Hazard of Antifibrinolytic Treatment in Menorrhagia
Stroke 21:817-819, Achiron,A.,et al, 1990
Combination of Aminocaproic Acid & Nicardipine in Treatment of Aneurysmal Subarachnoid Hemorrhage
Stroke 19:63-67, Beck,D.W.,et al, 1988
Antifibrinolytics in Subarachnoid Hemorrhage, Do They Have a Role? No
Arch Neurol 44:116-118, Weir,B., 1987
Antifibrinolytics in Aneurysmal Subarachnoid Hemorrhage, Do They Have a Role? Maybe
Arch Neurol 44:114-115, 1181987., Adams,H.P., 1987
Antifibrinolytic Treatment in Subarachnoid Hemorrhage
NEJM 311:432-437, Vermeulen,M.,et al, 1984
Current Status of Antifibrinolytic Therapy for Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage
Jr. , Stroke 13:256-259982., Adams,H.P., 1982
Antifibrinolytic Therapy in Patients With Aneurysmal Subarachnoid Hemorrhage
Jr. , et al, Arch Neurol 38:25-2981., Adams,H.P., 1981
Antifibrinolytic Therapy in Subarachnoid Hemorrhage Caused by Ruptured Intracranial Aneurysm
Neurol 31:316-322, Ramirez-Lassepas,M., 1981
Management of Cerebral Aneurysm
Stroke 12:273-283, Drake,C.G.,et al, 1981
Myopathy Due to Epsilon Amino-Caproic Acid
Muscle & Nerve 3:202-206980., Kennard,C.,et al, 1980
Treatment of Subarachnoid Hemorrhage from Ruptured Intracranial Aneurysm with Tranexamic Acid:A Double-blind Clinical Trial
Ann Neurol 3:502, Chandra,B., 1978
Effect of Tranexamic Acid on Rebleeding after Subarachnoid Hemorrhage:A Double-blind Controlled Clinical Trial
Ann Neurol 2:242, vanRossum,J.,et al, 1977
Spectrum of Intracranial Hemorrhages in Cerebral Venous Thrombosis, A Pictorial Case Series and Review of Pathophysiology and Management
Neurologist 30:45-51, Jha,S.,et al, 2025
Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025
Stroke-Like Migraine Attacks After Radiation Therapy Syndrome
Neurol 104:e210203, Lubotzky,A.,t al, 2025
FUTURE-AI: International Consensus Guideline for Trustworthy and Deployable Artificial Intelligence in Healthcare
BMJ 388:e081554, Lekadir,K.,et al, 2025
A 32 Year-Old Woman with Recurrent Intracerebral Hemorrhages
Neurol 104:e213422, Hindsholm,M.F.,et al, 2025
Black Turbinate Sign as an Early Clue of Rhino-Orbital-Cerebral Mucormycosis
Neurol 104:e210202, Xie,J.S.,et al, 2025
Clinical Presentation, Investigation Findings, and Outcomes of IgG4-Related Pachymeningitis,A Systematic Review
JAMA Neurol 82:193-199, Terrim,S.,et al, 2025
Methamphetamine-Induced Basal Ganglia Toxicity Presenting as Parkinsonism
Neurol 104:e213365, Yi,M.Y.,et al, 2025
Addressing Systemic Complications of Acute Stroke: A Scientific Statement From the American Heart Association
Stroke 56:e15-e29, Kumar,S.,et al, 2025
Commonly Used Interventional Procedures for Non-Cancer Chronic Spine Pain: A Clinical Practice Guideline
BMJ 388:e079970, Busse,J.W.,et al, 2025
Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma
NEJM 392:855-864, 918, Fiorella,D.,et al, 2025
Juvenile-Onset Dopa-Responsive Dystonia-Until It Isnt
Neurol 104:e213436, Paredes,N.C.,et al, 2025
Seizures, Driver Licensure, and Medical Reporting
Neurol 104:e213459, Tolchin,B.,et al, 2025
Calcitonin Gene-Related Peptide-Targeted Therapy in Migraine: Current Role and Future Perspectives
Lancet 405:1014-1026, Versijpt,J.,et al, 2025
Severe Myotonic Crisis Resembling Malignant Hyperthermia
Neurol 104:e213497, Wadhwani,A.R.,et al, 2025
Inebilizumab for Treatment of IgG4-Related Disease
NEJM 392:1168-1177, Stone,J.H.,et al, 2025
Beyond Glucocorticoids for IgG4-Related Disease
NEJM 392:1232-1233, Spiera,R., 2025
Alteplase for Posterior Circulation Ischemic Stropke at 4.5 to 24 Hours
NEJM 392:1288-1296, Yan,S.,et al, 2025
Left Atrial Appendage Closure After Ablation for Atrial Fibrillation
NEJM 392:1277-1287, Wazni,O.M.,et al, 2025
"Innumerable" lesion burden on brain MRI - a diagnostic approach
Diagnosis doi.org/10.1515/dx- 2025-2029, Finelli,P.F., 2025
Chronic Neuropsychiatric Sequelae Associated with Kambo Intoxication
JAMA Neurol 82:418-419, Jauregui,R.,et al, 2025
Long-Term Effects of Antidarsagene Autotemcel for Metachromatic Leukodystrophy
NEJM 392:1609-1620, Fumagalli,F.,et al, 2025
Anticoagulation or Antiplatelet Therapy for Device-Detected Atrial Fibrillation
NEJM 392:1749-1751, Gorey,S., 2025
Postprocedural Brachial Neuritis:Clinical, Electrodiagnostic, and Neuroimaging Features
AJNR 46:1050-1055, Ambati,V.S.,et al, 2025
Validation of an Artificial Intelligence-Powered Virtual Assistant for Emergency Triage in Neurology
Neurologist 30:155-163, Alessandro,L.,et al, 2025
Progress Toward Mitigating Disability Progression in Multiple Sclerosis
NEJM 392:1966-1968, Calabresi,P.A., 2025
General AI May Revolutionize Neurology 0 Or It Might be Bad
JAMA Neurol doi 10.1001/JAMANEUROL.2025.0905, Westover,M.B. & Westover,A.M., 2025